Anzeige
Mehr »
Login
Freitag, 24.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
InnoCan Pharma: Jetzt in die Doppel-Chance investieren?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CMT3 | ISIN: CA74880P1045 | Ticker-Symbol: 1P40
NASDAQ
23.05.24
22:00 Uhr
3,130 US-Dollar
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
QUIPT HOME MEDICAL CORP Chart 1 Jahr
5-Tage-Chart
QUIPT HOME MEDICAL CORP 5-Tage-Chart
GlobeNewswire (Europe)
112 Leser
Artikel bewerten:
(0)

Quipt Home Medical Corp.: Quipt Home Medical Announces Voting Results from Its Annual General and Special Meeting of Shareholders

CINCINNATI, March 28, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ: QIPT) (TSX: QIPT)?, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced the voting results from its annual general and special meeting of shareholders held on March 27, 2024 (the "Meeting") in Wilder, Kentucky. The total number of shares represented in person or by proxy at the Meeting was 25,432,699, representing 60.4% of the total issued and outstanding shares in the capital of the Company.

Election of Directors

The four candidates nominated for election to the Company's Board of Directors (the "Board") and listed in the Company's management information and proxy circular dated February 14, 2024 (the "Circular"), were elected by at least a majority of the shareholders present in person or represented by proxy at the Meeting. The voting results are as follows:

NameVotes For% ForVotes Withheld% Withheld
Gregory Crawford17,767,80477.74%5,088,93322.26%
Mark Greenberg17,425,38476.24%5,431,35323.76%
Kevin Carter20,217,07488.45%2,639,66311.55%
Brian Wessel20,239,14588.55%2,617,59211.45%

Appointment of Auditors

The Company's shareholders have approved the re-appointment of BDO USA, P.C. as the auditor of the Company for the fiscal year ended December 31, 2024 and authorized the Board to fix the auditor's remuneration.

Approval of the 2024 Equity Incentive Plan

The Company's shareholders have approved the 2024 Equity Incentive Plan of the Company (the "Incentive Plan"), ?pursuant to which the Company is able to issue share-based long-term incentives. All directors, officers, employees ?and service providers of the Company and/or its affiliates ??are eligible to receive awards under the Incentive Plan, subject to the ?terms of the Incentive Plan. Awards include common share purchase options, stock appreciation rights, restricted share awards, restricted share bonuses, restricted share units, performance shares, performance units, cash-based awards, and other share-based awards under the Incentive Plan. ??A copy of the Incentive Plan is attached as Schedule "A" to the Circular. As a result of the ?adoption of the Incentive Plan, no future awards or grants will be made under the ?Company's current equity incentive ?plan, which became effective on May 3, 2021.

A report of voting results describing each of the matters voted upon at the Meeting has been filed on SEDAR+ under the Company's issuer profile at www.sedarplus.ca.

ABOUT QUIPT HOME MEDICAL CORP.?

The Company provides in-home monitoring and disease management services including end-to-end respiratory ?solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include ?the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep ?disorders, reduced mobility and other chronic health conditions. The primary business objective of the Company is ?to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and ?chronic disease management. The Company's organic growth strategy is to increase annual revenue per patient by ?offering multiple services to the same patient, consolidating the patient's services and making life easier for the ?patient.?

For further information please visit our website at www.quipthomemedical.com, or contact:?

Cole Stevens
VP of Corporate Development
Quipt Home Medical Corp.
?859-300-6455
cole.stevens@myquipt.com

Gregory Crawford
Chief Executive Officer
Quipt Home Medical Corp.
?859-300-6455
investorinfo@myquipt.com


KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2024 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.